• Presenting the NeoVac library of innovation ionizable lipids and LNPs
• Tailoring activity, organ targeting and immunogenicity according to the intended intervention
• Revealing data from a clinical phase I/II study which demonstrate activity and superior safety

NEW DATA

NEW COMPANY